Agilent Technologies will report its fiscal second-quarter results after the market close tomorrow, with investors expecting revenue growth of 6% year over year, a slowdown from the 10.1% increase recorded in the same quarter last year. The company beat analysts' revenue expectations last quarter, posting $1.84 billion in revenue, up 10% year on year, and also exceeded organic revenue and full-year EPS guidance estimates. Analysts have generally reconfirmed their estimates over the past 30 days, and Agilent rarely misses Wall Street's revenue expectations. In the research tools and consumables segment, peers Avantor and Sotera Health Company have already reported, with Avantor posting flat revenue but beating expectations by 4.9% and Sotera Health reporting a 9.2% revenue increase, topping estimates by 3.8%. Agilent shares are up 12.4% over the last month, and the average analyst price target is $160.89, compared to the current share price of $154.98.
Agilent Technologies IncQ2 results due tomorrow; expectations of 6% revenue growth and prior beat, but no actual results yet.
Avantor IncPeer Avantor reported flat revenue but beat expectations, providing context for Agilent's upcoming results.
